Who Paid My Doc
CAPTIVA (Comparison of Anticoagulation vs anti-Platelet Therapies for Intracranial Vascular Atherostenosis)
Research payments
$3,558,959
Through program year 2024, $3,558,959 in research payments was reported against CAPTIVA (Comparison of Anticoagulation vs anti-Platelet Therapies for Intracranial Vascular Atherostenosis), across 4 payments, paid by AstraZeneca Pharmaceuticals LP.
- Paid by
- AstraZeneca Pharmaceuticals LP
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $1,504,334 | 1 |
| 2022 | Research | $2,034,805 | 2 |
| 2021 | Research | $19,820 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.